IL6 and glioma: These data implied that IL-6, IL-2, EGF, and VEGF produced in large quantities in the local lesions can be released into the blood circulation, and radiotherapy kills glioma cells and reduces the content of molecules related to proliferation activity in serum, but their effects were further enhanced with the addition of bevacizumab.